Edwards secures CE mark for EVOQUE tricuspid valve replacement system
Edwards Lifesciences has received the CE mark approval for its EVOQUE tricuspid valve replacement system to treat eligible patients with tricuspid regurgitation (TR). The EVOQUE system comes with